MCMCB Pro
G1023

G1023Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program

HCPCSTerminatedBETOS Z2

G1023 is a HCPCS Level II code for clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2024 and is not valid on new claims.

This code has been terminated

CMS terminated G1023 on December 31, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for G1023

Long descriptor
Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program

The official wording. This is what the code means.

Short descriptor
Cdsm persivia

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2020

When CMS introduced the code.

Terminated
December 31, 2024

When CMS retired it.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to G1023

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G1023 is not quite right, the correct code is very often within a few positions of it.

  • G1015Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria programterminated
  • G1016Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria programterminated
  • G1017Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria programterminated
  • G1018Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria programterminated
  • G1019Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria programterminated
  • G1020Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria programterminated
  • G1021Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria programterminated
  • G1022Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria programterminated
  • G1024Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria programterminated
  • G1025Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month
  • G1026The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month
  • G1027The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months
  • G1028Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
  • G2000Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session
  • G2001Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
  • G2002Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)

Questions about G1023

What is HCPCS code G1023?

G1023 is a HCPCS Level II code for clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G1023?

The CMS HCPCS file marks G1023 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

Is G1023 still valid?

No. G1023 was terminated on December 31, 2024 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026